T-Cell Project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma

• Autor(a) principal: Federico,Massimo
• Data de Publicação: 2009
• Outros Autores: Bellei,Monica, Pesce,Emanuela, Zucca,Emanuele, Pileri,Stefano, Montoto,Silvia, Weisenburger,Dennis D, Ruediger,Thomas, Ko.,Y. H., Liang,Raymond, Zinzani,Pier L., Connors,Joseph M., Foss,Francine M., Horwitz,Steven M., Polliack,Aaron, Vose,Julie M.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Revista brasileira de hematologia e hemoterapia (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842009000800007
• topic: T-cell lymphoma; outcome; chemotherapy; epidemiology

Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation and with different morphological patterns, phenotypes, and clinical presentations. PTCLs are highly diverse, reflecting the diverse cells from which they can originate and are currently sub-classified using World Health Organization (WHO) 2008 criteria. Peripheral T-Cell Lymphomas account for 5%-10% of all lymphoproliferative disorders in the Western hemisphere, with an overall incidence of 0.5-2 per 100,000 individuals per year, and have a striking epidemiological distribution, with higher incidence in Asia. The clinical features of PTCL are extremely heterogeneous. PTCLs express even more clinical diversity than B-cell non-Hodgkin's lymphomas, and there is a close, though not absolute, relationship between some unusual clinical features and certain histological subtypes.